The state murder trial of Francesco Mangione took a dramatic turn today as his legal team formally withdrew the psychiatric defence, a move that British legal experts are examining with intense interest. The decision, announced in a packed courtroom in Milan, signals a fundamental shift in strategy for the 42-year-old former physicist accused of the 2022 poisoning of his colleague, Dr. Elena Rossi.
Dr. Margherita Bianchi, Mangione's lead counsel, stated that the defence would no longer pursue arguments of diminished responsibility due to mental illness. Instead, the team will now focus on challenging the forensic evidence linking Mangione to the sodium azide compound used in the killing. “The science does not support the narrative the prosecution has constructed,” Bianchi told the court.
Professor Alistair Finch, a criminal law specialist at the University of Oxford, described the reversal as a high-risk gamble. “To withdraw a psychiatric defence mid-trial is unusual. It suggests either a lack of confidence in the expert testimony or a belief that the evidence on intent is weak. But it also exposes the defendant to a full mens rea argument, which the prosecution will exploit.”
The prosecution, led by Dr. Sofia Conti, has built its case around Mangione’s meticulous planning. Rossi’s body was found in her laboratory at the University of Padua, with traces of sodium azide in her coffee. Mangione, a rival researcher in quantum optics, had access to the chemical and was seen on CCTV tampering with the coffee machine. The initial psychiatric reports, commissioned by the defence, suggested that Mangione suffered from a paranoid delusional disorder that impaired his judgement. However, those reports have now been withdrawn.
“This is a pivot that may confuse the jury,” said Dr. Helena Vance, Science and Climate Correspondent. “The defence is essentially saying that Mangione was of sound mind but did not commit the act. That is a harder case to prove when the circumstantial evidence is as strong as it is here.”
British legal experts are scrutinising the Italian court’s handling of the defence shift. In the UK, such a change would require a formal application to the judge, with the prosecution given an opportunity to respond. The Italian system, which operates under a civil law framework, allows for greater flexibility but also raises concerns about procedural fairness.
“The judge has accepted the withdrawal without apparent objection,” noted Professor Finch. “But the jury will have heard the initial psychiatric testimony. It is difficult to unring that bell.”
The trial, which has garnered international attention, now enters a critical phase. Mangione’s team is expected to call alternative expert witnesses to challenge the forensic evidence, including the chain of custody of the sodium azide sample. The prosecution will likely counter with its own experts, reinforcing the timeline and motive.
Dr. Vance added: “In the court of public opinion, the narrative has already shifted. The abandonment of the mental health defence is seen by many as an admission that Mangione is not insane, but culpable. The burden now rests on the defence to dismantle the scientific case. It is a formidable task.”
The verdict, expected within weeks, could set a precedent for how Italian courts handle complex scientific evidence and psychiatric defences. For now, all eyes remain on the courtroom in Milan, where the fate of Francesco Mangione hangs in the balance.
